RESI 2018 – Boston (USA) - Temisis Therapeutics – Focusing on the development of small-molecule assets for the treatment of unmet needs in pathologies possessing a strong inflammatory component.

june, 2018

Redifining Early Stage Investment. Networking of entrepreneurs and investors in the field of life science.

(Monday) 0 h 00 min - 0 h 00 min